%PDF-1.6
%
1 0 obj
<>
endobj
2 0 obj
<>stream
Rocío Figueroa, Ana Alfonso, José López-Picazo, Ignacio Gil-Bazo, Alberto García-Mouriz, José Hermida, José Antonio Páramo, Ramón Lecumberri
Insights into venous thromboembolism prevention in hospitalized cancer patients: Lessons from a prospective study
www.plosone.org
www.plosone.org
endstream
endobj
3 0 obj
<>/XObject<>>>/CropBox[0 0 612 792]/MediaBox[0 0 612 792]/Parent 14 0 R/Annots 15 0 R/Contents 16 0 R/TrimBox[0 0 612 792]>>
endobj
15 0 obj
[17 0 R 18 0 R 19 0 R 20 0 R 21 0 R 22 0 R 23 0 R 24 0 R 25 0 R 26 0 R 27 0 R 28 0 R 29 0 R]
endobj
17 0 obj
<>/Border[0 0 0]/Dest(Rpone.0200220.ref005)>>
endobj
18 0 obj
<>/Border[0 0 0]/Dest(Rpone.0200220.ref006)>>
endobj
19 0 obj
<>/Border[0 0 0]/Dest(Rpone.0200220.ref007)>>
endobj
20 0 obj
<>/Border[0 0 0]/Dest(Rpone.0200220.ref008)>>
endobj
21 0 obj
<>/Border[0 0 0]/Dest(Rpone.0200220.ref010)>>
endobj
22 0 obj
<>/Border[0 0 0]/Dest(Rpone.0200220.ref011)>>
endobj
23 0 obj
<>/Border[0 0 0]/Dest(Rpone.0200220.ref012)>>
endobj
24 0 obj
<>/Border[0 0 0]/Dest(Rpone.0200220.ref013)>>
endobj
25 0 obj
<>/Border[0 0 0]/Dest(Rpone.0200220.ref015)>>
endobj
26 0 obj
<>/Border[0 0 0]/Dest(Rpone.0200220.ref016)>>
endobj
27 0 obj
<>/Border[0 0 0]/Dest(Rpone.0200220.ref017)>>
endobj
28 0 obj
<>/Border[0 0 0]/Dest(Rpone.0200220.ref018)>>
endobj
29 0 obj
<>/Border[0 0 0]/A 30 0 R>>
endobj
30 0 obj
<>
endobj
16 0 obj
[31 0 R 32 0 R 33 0 R 34 0 R 35 0 R 36 0 R 37 0 R 38 0 R 39 0 R 40 0 R 41 0 R 42 0 R 43 0 R 44 0 R 45 0 R]
endobj
31 0 obj
<>stream
q
0.83 0.64 0.02 0 k
348.4913 706.337 m
353.2535 706.337 l
h
f*
355.5213 706.337 m
360.2835 706.337 l
h
f*
529.3417 693.2976 m
534.1039 693.2976 l
h
f*
310.0535 654.3496 m
314.8157 654.3496 l
h
f*
319.9748 654.3496 m
329.4992 654.3496 l
h
f*
395.3764 615.3449 m
404.9008 615.3449 l
h
f*
410.0598 615.3449 m
419.5843 615.3449 l
h
f*
278.5323 576.3402 m
288.0567 576.3402 l
h
f*
293.2724 576.3402 m
302.7402 576.3402 l
h
f*
203.4142 367.937 m
212.9386 367.937 l
h
f*
215.1496 367.937 m
224.674 367.937 l
h
f*
467.6598 107.9433 m
477.1843 107.9433 l
h
f*
0 g
1 j
1 J
0 w
10 0 0 10 200.0125 707.4141 cm
BT
/F6 1 Tf
1 TL
-0.004 Tc
0 0 Td
(in)Tj
1.0318 0 Td
(case)Tj
1.8651 0 Td
(of)Tj
1.0148 0 Td
(developing)Tj
4.5978 0 Td
(a)Tj
0.6576 0 Td
(VTE)Tj
2.092 0 Td
(episode)Tj
3.2485 0 Td
([)Tj
0.83 0.64 0.02 0 k
(5)Tj
0 g
(,)Tj
0.83 0.64 0.02 0 k
(6)Tj
0 g
(].)Tj
2.3017 0 Td
(The)Tj
1.7858 0 Td
(morbidity)Tj
4.2349 0 Td
(and)Tj
1.7348 0 Td
(economic)Tj
4.1386 0 Td
(burden)Tj
3.1238 0 Td
(of)Tj
1.0147 0 Td
(CAT)Tj
2.177 0 Td
(has)Tj
-35.0189 -1.3039 Td
(encouraged)Tj
4.8698 0 Td
(different)Tj
3.6567 0 Td
(projects)Tj
3.3789 0 Td
(aimed)Tj
2.6929 0 Td
(to)Tj
1.0261 0 Td
(increase)Tj
3.4696 0 Td
(awareness)Tj
4.2633 0 Td
(on)Tj
1.2756 0 Td
(this)Tj
1.6724 0 Td
(health)Tj
2.6759 0 Td
(problem)Tj
3.6113 0 Td
([)Tj
0.83 0.64 0.02 0 k
(7)Tj
0 g
(].)Tj
-31.3963 -1.2982 Td
(CAT)Tj
2.177 0 Td
(is)Tj
0.8447 0 Td
(considered)Tj
4.5921 0 Td
(a)Tj
0.6519 0 Td
(potentially)Tj
4.4561 0 Td
(avoidable)Tj
4.0138 0 Td
(condition)Tj
4.1102 0 Td
(and)Tj
1.7235 0 Td
(several)Tj
2.931 0 Td
(risk)Tj
1.7121 0 Td
(factors)Tj
2.897 0 Td
(have)Tj
2.0523 0 Td
(been)Tj
2.1203 0 Td
(iden-)Tj
-35.4782 -1.2983 Td
(tified.)Tj
2.5171 0 Td
(Among)Tj
3.2428 0 Td
(them,)Tj
2.5172 0 Td
(hospital)Tj
3.3788 0 Td
(admission)Tj
4.3087 0 Td
(is)Tj
0.8504 0 Td
(one)Tj
1.7007 0 Td
(of)Tj
1.0148 0 Td
(the)Tj
1.4684 0 Td
(most)Tj
2.2053 0 Td
(frequent,)Tj
3.8324 0 Td
(contributing)Tj
5.2498 0 Td
(to)Tj
1.0261 0 Td
(approxi-)Tj
-33.3125 -1.2983 Td
(mately)Tj
2.8969 0 Td
(50%)Tj
1.9276 0 Td
(of)Tj
1.0148 0 Td
(VTE)Tj
2.0919 0 Td
(events)Tj
2.7326 0 Td
([)Tj
0.83 0.64 0.02 0 k
(8)Tj
0 g
()Tj
0.83 0.64 0.02 0 k
(10)Tj
0 g
(].)Tj
3.0671 0 Td
(Despite)Tj
3.2485 0 Td
(specific)Tj
3.1918 0 Td
(studies)Tj
2.9877 0 Td
(in)Tj
1.0318 0 Td
(the)Tj
1.474 0 Td
(cancer)Tj
2.8403 0 Td
(setting)Tj
2.8856 0 Td
(are)Tj
1.4457 0 Td
(lacking,)Tj
-32.8363 -1.3039 Td
(clinical)Tj
3.0727 0 Td
(practice)Tj
3.3789 0 Td
(guidelines)Tj
4.2803 0 Td
(recommend)Tj
5.0853 0 Td
(routine)Tj
3.1634 0 Td
(prophylaxis)Tj
4.8869 0 Td
(with)Tj
1.9956 0 Td
(low)Tj
1.6611 0 Td
(molecular)Tj
4.2179 0 Td
(weight)Tj
2.8857 0 Td
(hepa-)Tj
-34.6278 -1.2982 Td
(rin)Tj
1.4059 0 Td
(\(LMWH\))Tj
4.0649 0 Td
(in)Tj
1.0375 0 Td
(most)Tj
2.2053 0 Td
(hospitalized)Tj
5.0059 0 Td
(cancer)Tj
2.846 0 Td
(patients,)Tj
3.5943 0 Td
(unless)Tj
2.6873 0 Td
(contraindicated,)Tj
6.7464 0 Td
(except)Tj
2.7722 0 Td
(for)Tj
1.3833 0 Td
(those)Tj
-33.749 -1.2983 Td
(admitted)Tj
3.8154 0 Td
(exclusively)Tj
4.5127 0 Td
(for)Tj
1.389 0 Td
(chemotherapy)Tj
5.947 0 Td
(infusion)Tj
3.5319 0 Td
([)Tj
0.83 0.64 0.02 0 k
(11)Tj
0 g
()Tj
0.83 0.64 0.02 0 k
(12)Tj
0 g
(].)Tj
-17.9998 -1.3039 Td
(Data)Tj
2.1259 0 Td
(on)Tj
1.2756 0 Td
(pharmacologic)Tj
6.1625 0 Td
(thromboprophylaxis)Tj
8.4245 0 Td
(rate)Tj
1.7461 0 Td
(in)Tj
1.0375 0 Td
(hospitalized)Tj
5.0116 0 Td
(cancer)Tj
2.846 0 Td
(patients)Tj
3.3675 0 Td
(are)Tj
1.4457 0 Td
(scarce,)Tj
-34.6391 -1.2983 Td
(but)Tj
1.5533 0 Td
(uniformly)Tj
4.2463 0 Td
(show)Tj
2.3017 0 Td
(a)Tj
0.652 0 Td
(global)Tj
2.6305 0 Td
(underuse.)Tj
4.1556 0 Td
(Retrospective)Tj
5.6069 0 Td
(studies)Tj
2.9877 0 Td
(have)Tj
2.0579 0 Td
(shown)Tj
2.8516 0 Td
(prophylaxis)Tj
4.8869 0 Td
(rates)Tj
-33.9304 -1.2983 Td
(between)Tj
3.5262 0 Td
(18%-56%)Tj
3.9855 0 Td
([)Tj
0.83 0.64 0.02 0 k
(13)Tj
0 g
()Tj
0.83 0.64 0.02 0 k
(15)Tj
0 g
(].)Tj
3.549 0 Td
(A)Tj
0.9014 0 Td
(deeper)Tj
2.9083 0 Td
(knowledge)Tj
4.5411 0 Td
(of)Tj
1.0148 0 Td
(current)Tj
3.1861 0 Td
(thromboprophylaxis)Tj
8.4245 0 Td
(practice)Tj
3.3789 0 Td
(in)Tj
-35.4158 -1.3039 Td
(hospitalized)Tj
5.0059 0 Td
(cancer)Tj
2.846 0 Td
(patients)Tj
3.3675 0 Td
(and)Tj
1.7291 0 Td
(the)Tj
1.474 0 Td
(factors)Tj
2.9027 0 Td
(that)Tj
1.7745 0 Td
(influence)Tj
3.9174 0 Td
(its)Tj
1.1509 0 Td
(use)Tj
1.5307 0 Td
(could)Tj
2.4491 0 Td
(be)Tj
1.1509 0 Td
(of)Tj
1.0148 0 Td
(value)Tj
2.3073 0 Td
(for)Tj
1.389 0 Td
(health)Tj
-34.0098 -1.2982 Td
(stakeholders)Tj
5.1987 0 Td
(in)Tj
1.0318 0 Td
(order)Tj
2.4207 0 Td
(to)Tj
1.0262 0 Td
(design)Tj
2.8119 0 Td
(appropriate)Tj
4.8812 0 Td
(strategies)Tj
3.9232 0 Td
(to)Tj
1.0261 0 Td
(improve)Tj
3.5773 0 Td
(quality)Tj
2.9537 0 Td
(of)Tj
1.0148 0 Td
(care.)Tj
2.0976 0 Td
(For)Tj
1.6271 0 Td
(this)Tj
1.6781 0 Td
(pur-)Tj
-35.2684 -1.2983 Td
(pose,)Tj
2.2506 0 Td
(we)Tj
1.3323 0 Td
(have)Tj
2.058 0 Td
(designed)Tj
3.7643 0 Td
(a)Tj
0.652 0 Td
(prospective)Tj
4.7849 0 Td
(study,)Tj
2.6135 0 Td
(aimed)Tj
2.6929 0 Td
(to)Tj
1.0261 0 Td
(assess)Tj
2.5228 0 Td
(the)Tj
1.4684 0 Td
(rate)Tj
1.7461 0 Td
(of)Tj
1.0148 0 Td
(VTE)Tj
2.0976 0 Td
(pharmacologic)Tj
-30.0243 -1.3039 Td
(prophylaxis)Tj
4.8868 0 Td
(use)Tj
1.5307 0 Td
(in)Tj
1.0375 0 Td
(cancer)Tj
2.846 0 Td
(hospitalized)Tj
5.0059 0 Td
(patients)Tj
3.3732 0 Td
(in)Tj
1.0319 0 Td
(daily)Tj
2.1486 0 Td
(practice)Tj
3.3789 0 Td
(and)Tj
1.7348 0 Td
(identify)Tj
3.2938 0 Td
(variables)Tj
3.719 0 Td
(related)Tj
-33.9871 -1.2983 Td
(with)Tj
1.9955 0 Td
(its)Tj
1.1452 0 Td
(prescription)Tj
5.0967 0 Td
(and)Tj
1.7291 0 Td
(outcome.)Tj
ET
Q
q
1 j
1 J
0 w
11.9999 0 0 11.9999 200.0125 482.0031 cm
BT
/F2 1 Tf
1 TL
-0.0033 Tc
0 0 Td
(Materials)Tj
4.5071 0 Td
(and)Tj
1.989 0 Td
(methods)Tj
/F11 1 Tf
-6.4961 -1.5023 Td
(Study)Tj
2.6173 0 Td
(design)Tj
ET
Q
q
1 j
1 J
0 w
10 0 0 10 200.0125 447.0236 cm
BT
/F6 1 Tf
1 TL
-0.004 Tc
0 0 Td
(Prospective)Tj
4.8245 0 Td
(cohort)Tj
2.8573 0 Td
(study,)Tj
2.6135 0 Td
(including)Tj
4.0422 0 Td
(consecutive)Tj
4.8756 0 Td
(adult)Tj
2.2563 0 Td
(medical)Tj
3.3619 0 Td
(cancer)Tj
2.846 0 Td
(patients)Tj
3.3675 0 Td
(\()Tj
/F5 1 Tf
0 Tc
()Tj
/F6 1 Tf
-0.004 Tc
1.3323 0 Td
(18)Tj
1.1678 0 Td
(years-)Tj
-33.5449 -1.3039 Td
(old\),)Tj
2.0636 0 Td
(not)Tj
1.576 0 Td
(receiving)Tj
3.8664 0 Td
(anticoagulant)Tj
5.6523 0 Td
(therapy,)Tj
3.4696 0 Td
(admitted)Tj
3.8154 0 Td
(in)Tj
1.0375 0 Td
(the)Tj
1.4683 0 Td
(Oncology)Tj
4.1215 0 Td
(and)Tj
1.7292 0 Td
(Hematology)Tj
5.142 0 Td
(Depart-)Tj
-33.9418 -1.2982 Td
(ments)Tj
2.6702 0 Td
(at)Tj
0.9524 0 Td
(the)Tj
1.4683 0 Td
(University)Tj
4.4051 0 Td
(Clinic)Tj
2.6362 0 Td
(of)Tj
1.0148 0 Td
(Navarra)Tj
3.4525 0 Td
(from)Tj
2.2054 0 Td
(April)Tj
2.3074 0 Td
(2014)Tj
2.1203 0 Td
(to)Tj
1.0261 0 Td
(February)Tj
3.8381 0 Td
(2017.)Tj
2.3471 0 Td
(The)Tj
1.7858 0 Td
(study)Tj
2.3867 0 Td
(was)Tj
-34.6164 -1.2983 Td
(approved)Tj
3.9741 0 Td
(by)Tj
1.1792 0 Td
(the)Tj
1.4683 0 Td
(institutional)Tj
5.091 0 Td
(Ethics)Tj
2.6646 0 Td
(Committee)Tj
4.7451 0 Td
(and)Tj
1.7292 0 Td
(all)Tj
1.1452 0 Td
(patients)Tj
3.3675 0 Td
(signed)Tj
2.812 0 Td
(an)Tj
1.2018 0 Td
(informed)Tj
3.9742 0 Td
(consent.)Tj
-32.156 -1.3039 Td
(The)Tj
1.7858 0 Td
(risk)Tj
1.7178 0 Td
(of)Tj
1.0148 0 Td
(VTE)Tj
2.0919 0 Td
(of)Tj
1.0148 0 Td
(all)Tj
1.1452 0 Td
(patients)Tj
3.3675 0 Td
(was)Tj
1.7008 0 Td
(automatically)Tj
5.6126 0 Td
(calculated)Tj
4.2009 0 Td
(daily)Tj
2.1543 0 Td
(by)Tj
1.1792 0 Td
(using)Tj
2.3924 0 Td
(an)Tj
1.2019 0 Td
(application)Tj
4.6772 0 Td
(of)Tj
-36.4533 -1.2983 Td
(the)Tj
1.4683 0 Td
(Institution)Tj
4.4844 0 Td
(electronic)Tj
4.1499 0 Td
(clinical)Tj
3.0784 0 Td
(history)Tj
3.0047 0 Td
(software)Tj
3.5886 0 Td
(following)Tj
3.9798 0 Td
(the)Tj
1.4684 0 Td
(validated)Tj
3.8324 0 Td
(PRETEMED)Tj
5.3518 0 Td
(scale)Tj
-34.4067 -1.2982 Td
([)Tj
0.83 0.64 0.02 0 k
(16)Tj
0 g
(,)Tj
0.83 0.64 0.02 0 k
(17)Tj
0 g
(].)Tj
3.2541 0 Td
(In)Tj
1.1055 0 Td
(this)Tj
1.6781 0 Td
(point)Tj
2.3527 0 Td
(scale)Tj
2.109 0 Td
(major)Tj
2.6079 0 Td
(risk)Tj
1.7178 0 Td
(factors)Tj
2.9026 0 Td
(such)Tj
2.058 0 Td
(as)Tj
1.0204 0 Td
(active)Tj
2.5172 0 Td
(cancer,)Tj
3.0727 0 Td
(previous)Tj
3.6453 0 Td
(VTE,)Tj
2.3244 0 Td
(acute)Tj
2.3244 0 Td
(myo-)Tj
-34.6901 -1.304 Td
(cardial)Tj
2.9253 0 Td
(infarction,)Tj
4.3937 0 Td
(ischaemic)Tj
4.1669 0 Td
(stroke)Tj
2.6815 0 Td
(with)Tj
1.9956 0 Td
(limb)Tj
2.0579 0 Td
(paralysis,)Tj
3.8948 0 Td
(decompensated)Tj
6.4516 0 Td
(chronic)Tj
3.2939 0 Td
(obstructive)Tj
-31.8612 -1.2982 Td
(pulmonary)Tj
4.6431 0 Td
(disease)Tj
3.0217 0 Td
(and)Tj
1.7291 0 Td
(thrombophilia)Tj
6.0151 0 Td
(were)Tj
2.126 0 Td
(assigned)Tj
3.6056 0 Td
(a)Tj
0.652 0 Td
(score)Tj
2.3074 0 Td
(of)Tj
1.0148 0 Td
(3;)Tj
0.924 0 Td
(congestive)Tj
4.388 0 Td
(heart)Tj
2.2791 0 Td
(failure,)Tj
-32.7059 -1.2983 Td
(chronic)Tj
3.2824 0 Td
(renal)Tj
2.2451 0 Td
(insufficiency/nephrotic)Tj
9.5187 0 Td
(syndrome,)Tj
4.456 0 Td
(severe)Tj
2.6702 0 Td
(acute)Tj
2.3244 0 Td
(infection,)Tj
4.0138 0 Td
(lower)Tj
2.4492 0 Td
(limb)Tj
2.0579 0 Td
(cast)Tj
1.7348 0 Td
(or)Tj
1.0942 0 Td
(pro-)Tj
-35.8467 -1.2983 Td
(longed)Tj
2.9366 0 Td
(bed)Tj
1.6781 0 Td
(rest)Tj
1.6725 0 Td
(were)Tj
2.1259 0 Td
(assigned)Tj
3.6057 0 Td
(a)Tj
0.6519 0 Td
(score)Tj
2.3074 0 Td
(of)Tj
1.0148 0 Td
(2;)Tj
0.9241 0 Td
(pregnancy/postpartum)Tj
9.3883 0 Td
(period,)Tj
3.0557 0 Td
(recent)Tj
2.7099 0 Td
(prolonged)Tj
-32.0709 -1.3039 Td
(flight,)Tj
2.5341 0 Td
(lower)Tj
2.4548 0 Td
(limb)Tj
2.0579 0 Td
(paresis,)Tj
3.1805 0 Td
(estrogen)Tj
3.6226 0 Td
(therapy,)Tj
3.4696 0 Td
(thalidomide/lenalidomide)Tj
10.6355 0 Td
(administration,)Tj
6.395 0 Td
(use)Tj
1.5307 0 Td
(of)Tj
-35.8807 -1.2982 Td
(central)Tj
2.965 0 Td
(vein)Tj
1.9105 0 Td
(catheter,)Tj
3.651 0 Td
(obesity,)Tj
3.2598 0 Td
(age)Tj
/F12 1 Tf
0 Tc
1.5421 0 Td
(>)Tj
/F6 1 Tf
-0.004 Tc
0.9921 0 Td
(60)Tj
1.1735 0 Td
(years)Tj
2.2621 0 Td
(or)Tj
1.0998 0 Td
(smoking)Tj
3.685 0 Td
(were)Tj
2.1203 0 Td
(assigned)Tj
3.6113 0 Td
(a)Tj
0.652 0 Td
(score)Tj
2.3074 0 Td
(of)Tj
1.0148 0 Td
(1.)Tj
0.9184 0 Td
(High)Tj
2.2507 0 Td
(risk)Tj
-35.4158 -1.2983 Td
(of)Tj
1.0147 0 Td
(VTE)Tj
2.092 0 Td
(was)Tj
1.7008 0 Td
(defined)Tj
3.2258 0 Td
(as)Tj
1.0148 0 Td
(a)Tj
0.6519 0 Td
(cumulative)Tj
4.6432 0 Td
(score)Tj
2.3074 0 Td
(of)Tj
1.0148 0 Td
(at)Tj
0.9524 0 Td
(least)Tj
1.9842 0 Td
(4)Tj
0.6973 0 Td
(points.)Tj
2.9424 0 Td
(According)Tj
4.439 0 Td
(to)Tj
1.0261 0 Td
(our)Tj
1.6215 0 Td
(institutional)Tj
-31.3283 -1.3039 Td
(thromboprophylaxis)Tj
8.4245 0 Td
(protocol,)Tj
3.821 0 Td
(medical)Tj
3.3619 0 Td
(inpatients)Tj
4.1839 0 Td
(with)Tj
2.0013 0 Td
(high)Tj
2.0069 0 Td
(risk)Tj
1.7178 0 Td
(of)Tj
1.0148 0 Td
(VTE,)Tj
2.3187 0 Td
(including)Tj
4.0422 0 Td
(cancer)Tj
-32.893 -1.2983 Td
(patients,)Tj
3.5943 0 Td
(should)Tj
2.914 0 Td
(receive)Tj
3.0103 0 Td
(3500)Tj
2.1203 0 Td
(IU)Tj
1.2983 0 Td
(of)Tj
1.0148 0 Td
(bemiparin)Tj
4.371 0 Td
(daily,)Tj
2.3754 0 Td
(unless)Tj
2.6929 0 Td
(contraindicated.)Tj
6.7407 0 Td
(In)Tj
1.1112 0 Td
(case)Tj
1.8595 0 Td
(of)Tj
1.0148 0 Td
(with-)Tj
-34.1175 -1.2982 Td
(holding)Tj
3.3108 0 Td
(LMWH)Tj
3.3789 0 Td
(prophylaxis)Tj
4.8925 0 Td
(in)Tj
1.0318 0 Td
(a)Tj
0.6577 0 Td
(patient)Tj
3.0047 0 Td
(with)Tj
2.0012 0 Td
(high-risk)Tj
3.8495 0 Td
(score,)Tj
2.5341 0 Td
(the)Tj
1.4683 0 Td
(application)Tj
4.6829 0 Td
(asked)Tj
2.4604 0 Td
(the)Tj
-33.2728 -1.304 Td
(responsible)Tj
4.7508 0 Td
(physician)Tj
4.0195 0 Td
(to)Tj
1.0261 0 Td
(explain)Tj
3.1238 0 Td
(the)Tj
1.4683 0 Td
(reason.)Tj
-13.1923 -1.2982 Td
(Primary)Tj
3.4979 0 Td
(outcome)Tj
3.7304 0 Td
(of)Tj
1.0148 0 Td
(the)Tj
1.4683 0 Td
(study)Tj
2.3868 0 Td
(was)Tj
1.7007 0 Td
(the)Tj
1.4684 0 Td
(rate)Tj
1.7461 0 Td
(of)Tj
1.0148 0 Td
(thromboprophylaxis)Tj
8.4302 0 Td
(use.)Tj
1.7574 0 Td
(Secondary)Tj
4.3824 0 Td
(end-)Tj
-33.7944 -1.2983 Td
(points)Tj
2.7155 0 Td
(were)Tj
2.126 0 Td
(the)Tj
1.4683 0 Td
(incidence)Tj
4.0706 0 Td
(of)Tj
1.0148 0 Td
(VTE,)Tj
2.3243 0 Td
(major)Tj
2.6079 0 Td
(bleeding)Tj
3.6283 0 Td
(and)Tj
1.7292 0 Td
(mortality)Tj
3.9174 0 Td
(during)Tj
2.931 0 Td
(follow-up.)Tj
4.3143 0 Td
(VTE)Tj
2.0976 0 Td
(events)Tj
-34.9452 -1.3039 Td
(had)Tj
1.7064 0 Td
(to)Tj
1.0261 0 Td
(be)Tj
1.1509 0 Td
(objectively)Tj
4.4844 0 Td
(confirmed)Tj
4.3936 0 Td
(by)Tj
1.1849 0 Td
(ultrasonography)Tj
6.7861 0 Td
(or)Tj
1.0999 0 Td
(contrast)Tj
3.4639 0 Td
(venography)Tj
4.9209 0 Td
(\(for)Tj
1.7291 0 Td
(deep)Tj
2.109 0 Td
(venous)Tj
-34.0552 -1.2983 Td
(thrombosis)Tj
4.7451 0 Td
([DVT]\))Tj
3.2825 0 Td
(and)Tj
1.7291 0 Td
(computed)Tj
4.2633 0 Td
(tomography)Tj
5.125 0 Td
(or)Tj
1.0999 0 Td
(pulmonary)Tj
4.6431 0 Td
(ventilation/perfusion)Tj
8.6569 0 Td
(scan)Tj
1.9843 0 Td
(\(for)Tj
-35.5292 -1.2982 Td
(pulmonary)Tj
4.6431 0 Td
(embolism)Tj
4.1725 0 Td
([PE]\).)Tj
2.5966 0 Td
(Major)Tj
2.6815 0 Td
(bleeding)Tj
3.6283 0 Td
(was)Tj
1.6952 0 Td
(defined)Tj
3.2258 0 Td
(as)Tj
1.0148 0 Td
(any)Tj
1.661 0 Td
(fatal)Tj
1.9219 0 Td
(bleeding)Tj
3.6283 0 Td
(and/or)Tj
2.9367 0 Td
(symp-)Tj
-33.8057 -1.2983 Td
(tomatic)Tj
3.2654 0 Td
(bleeding)Tj
3.6284 0 Td
(in)Tj
1.0374 0 Td
(a)Tj
0.652 0 Td
(critical)Tj
2.9537 0 Td
(area)Tj
1.8822 0 Td
(or)Tj
1.0998 0 Td
(organ,)Tj
2.7666 0 Td
(extra)Tj
2.2167 0 Td
(surgical)Tj
3.3165 0 Td
(site)Tj
1.5704 0 Td
(bleeding)Tj
3.6283 0 Td
(causing)Tj
3.2428 0 Td
(a)Tj
0.6577 0 Td
(fall)Tj
1.4343 0 Td
(in)Tj
1.0318 0 Td
(haemo-)Tj
-34.384 -1.3039 Td
(globin)Tj
2.7609 0 Td
(level)Tj
/F5 1 Tf
0 Tc
2.0126 0 Td
()Tj
/F6 1 Tf
-0.004 Tc
(20)Tj
1.9445 0 Td
(g/L,)Tj
1.7745 0 Td
(or)Tj
1.0998 0 Td
(leading)Tj
3.1351 0 Td
(to)Tj
1.0262 0 Td
(transfusion)Tj
4.7281 0 Td
(of)Tj
1.0148 0 Td
(two)Tj
1.7121 0 Td
(or)Tj
1.0999 0 Td
(more)Tj
2.3414 0 Td
(units)Tj
2.2223 0 Td
(of)Tj
1.0148 0 Td
(whole)Tj
2.6079 0 Td
(blood)Tj
2.5115 0 Td
(or)Tj
1.0998 0 Td
(red)Tj
1.542 0 Td
(cells)Tj
-35.6482 -1.2983 Td
(and/or)Tj
2.9366 0 Td
(surgical)Tj
3.3165 0 Td
(site)Tj
1.5704 0 Td
(bleeding)Tj
3.6283 0 Td
(that)Tj
1.7802 0 Td
(requires)Tj
3.4696 0 Td
(a)Tj
0.6519 0 Td
(second)Tj
3.0161 0 Td
(intervention)Tj
5.176 0 Td
(or)Tj
1.0942 0 Td
(that)Tj
1.7801 0 Td
(is)Tj
0.8504 0 Td
(unexpected)Tj
4.7962 0 Td
(and)Tj
1.7291 0 Td
(pro-)Tj
-35.7956 -1.2983 Td
(longed)Tj
2.9366 0 Td
(and/)Tj
2.058 0 Td
(or)Tj
1.0998 0 Td
(sufficiently)Tj
4.6148 0 Td
(large)Tj
2.16 0 Td
(to)Tj
1.0261 0 Td
(cause)Tj
2.3868 0 Td
(hemodynamic)Tj
5.9753 0 Td
(instability)Tj
4.167 0 Td
([)Tj
0.83 0.64 0.02 0 k
(18)Tj
0 g
(].)Tj
-25.2282 -1.3039 Td
(Follow-up)Tj
4.3369 0 Td
(period)Tj
2.8347 0 Td
(comprised)Tj
4.439 0 Td
(from)Tj
2.2053 0 Td
(admission)Tj
4.3087 0 Td
(to)Tj
1.0261 0 Td
(30)Tj
1.1735 0 Td
(days)Tj
1.9956 0 Td
(after)Tj
2.0353 0 Td
(discharge.)Tj
4.2463 0 Td
(Main)Tj
2.364 0 Td
(clinical)Tj
3.0728 0 Td
(data,)Tj
-35.2344 -1.2982 Td
(VTE)Tj
2.0919 0 Td
(risk)Tj
1.7121 0 Td
(score)Tj
2.3017 0 Td
(and)Tj
1.7292 0 Td
(pharmacologic)Tj
6.1568 0 Td
(thromboprophylaxis)Tj
8.4245 0 Td
(use)Tj
1.5307 0 Td
(were)Tj
2.1203 0 Td
(provided)Tj
3.8097 0 Td
(by)Tj
1.1792 0 Td
(multiple)Tj
3.566 0 Td
(sources)Tj
ET
Q
q
1 j
1 J
0 w
576 737.1 m
36 737.1 l
36 737.6 l
576 737.6 l
f*
36 741.2598 107.1496 23.6976 re
W* n
q
107.0929 0 0 23.6409 36 741.3165 cm
q
/I0 Do
Q
Q
Q
q
0 0 612 792 re
W* n
1 j
1 J
0 w
7.9999 0 0 7.9999 299.0551 745.7952 cm
BT
/F0 1 Tf
1 TL
-0.005 Tc
0 0 Td
(Insights)Tj
3.6071 0 Td
(into)Tj
1.8 0 Td
(venous)Tj
3.3874 0 Td
(thromboe)Tj
4.1528 0 Td
(mbolism)Tj
3.8835 0 Td
(prevention)Tj
4.8048 0 Td
(in)Tj
0.9779 0 Td
(hospitali)Tj
3.5859 0 Td
(zed)Tj
1.8071 0 Td
(cancer)Tj
3.1677 0 Td
(patients)Tj
ET
Q
q
1 j
1 J
0 w
36 48.0002 m
576 48.0002 l
576 47.5002 l
36 47.5002 l
f*
0.83 0.64 0.02 0 k
81.5811 34.9228 m
237.8835 34.9228 l
h
f*
0 g
7.9999 0 0 7.9999 36 36 cm
BT
/F0 1 Tf
1 TL
-0.005 Tc
0 0 Td
(PLOS)Tj
2.8559 0 Td
(ONE)Tj
2.3669 0 Td
(|)Tj
0.83 0.64 0.02 0 k
0.4748 0 Td
(https://doi.or)Tj
5.4142 0 Td
(g/10.137)Tj
3.8198 0 Td
(1/journal.po)Tj
5.1236 0 Td
(ne.02002)Tj
4.089 0 Td
(20)Tj
0 g
2.0906 0 Td
(August)Tj
3.2882 0 Td
(2,)Tj
1.0418 0 Td
(2018)Tj
35.1215 0 Td
(2)Tj
0.7654 0 Td
(/)Tj
0.496 0 Td
(8)Tj
/F8 1 Tf
-0.025 Tc
-66.9477 84.0904 Td
(Competing)Tj
4.3795 0 Td
(interests)Tj
3.3307 0 Td
(:)Tj
/F9 1 Tf
0.4819 0 Td
(R.)Tj
1.0276 0 Td
(Lecumberri)Tj
4.4646 0 Td
(declares)Tj
-13.6843 -1.3748 Td
(speaker)Tj
3.111 0 Td
(honorari)Tj
3.1181 0 Td
(a)Tj
0.6449 0 Td
(from)Tj
2.0055 0 Td
(Rovi)Tj
1.8993 0 Td
(and)Tj
1.5874 0 Td
(Boehringer)Tj
-12.3662 -1.3749 Td
(Ingelheim,)Tj
4.1031 0 Td
(and)Tj
1.5874 0 Td
(advisory)Tj
3.352 0 Td
(boards)Tj
2.7922 0 Td
(for)Tj
1.2543 0 Td
(Sanofi,)Tj
2.7851 0 Td
(Leo-)Tj
-15.8741 -1.3748 Td
(Pharma,)Tj
3.3449 0 Td
(BMS,)Tj
2.2535 0 Td
(Daiichi)Tj
2.7 0 Td
(Sankyo)Tj
2.9552 0 Td
(and)Tj
1.5874 0 Td
(Bayer.)Tj
2.5441 0 Td
(The)Tj
1.5874 0 Td
(other)Tj
-16.9725 -1.3748 Td
(authors)Tj
3.0472 0 Td
(declare)Tj
2.8772 0 Td
(no)Tj
1.1693 0 Td
(conflicts)Tj
3.3237 0 Td
(of)Tj
0.9496 0 Td
(interest.)Tj
3.1961 0 Td
(This)Tj
1.7787 0 Td
(does)Tj
-16.3418 -1.3748 Td
(not)Tj
1.4244 0 Td
(alter)Tj
1.8142 0 Td
(the)Tj
1.3748 0 Td
(authors)Tj
2.8205 0 Td
(')Tj
0.4181 0 Td
(adherenc)Tj
3.4087 0 Td
(e)Tj
0.6449 0 Td
(to)Tj
0.9496 0 Td
(PLOS)Tj
2.3315 0 Td
(ONE)Tj
-15.1867 -1.3748 Td
(policies)Tj
3.0118 0 Td
(on)Tj
1.1622 0 Td
(sharing)Tj
2.9835 0 Td
(data)Tj
1.7929 0 Td
(and)Tj
ET
endstream
endobj
32 0 obj
<>stream
endstream
endobj
33 0 obj
<>stream
endstream
endobj
34 0 obj
<>stream
endstream
endobj
35 0 obj
<>stream
endstream
endobj
36 0 obj
<>stream
endstream
endobj
37 0 obj
<>stream
endstream
endobj
38 0 obj
<>stream
endstream
endobj
39 0 obj
<>stream
endstream
endobj
40 0 obj
<>stream
endstream
endobj
41 0 obj
<>stream
endstream
endobj
42 0 obj
<>stream
endstream
endobj
43 0 obj
<>stream
endstream
endobj
44 0 obj
<>stream
endstream
endobj
45 0 obj
<>stream
BT
10.5378 75.8415 Td
(materials.)Tj
ET
Q
endstream
endobj
46 0 obj
<>/XObject<>>>/CropBox[0 0 612 792]/MediaBox[0 0 612 792]/Parent 14 0 R/Annots 49 0 R/Contents 50 0 R/TrimBox[0 0 612 792]>>
endobj
47 0 obj
<>
endobj
51 0 obj
<>
endobj
54 0 obj
<>stream
MinionPro-Regular 6 )
H? HD H\ ' - 3 > H N T Z ` j q t { +2=CIU[cnz~
"(.9CIOU[elov|&-8>DPV^iuy &+/49@DGLPU[]_ahjmru|
&-4;BIPW^elsz
")07>ELSZahov} %,3:AHOV]dkry#/;JTey ! ( / 6 = D K R Y ` g n u |
$
+
2
9
@
G
N
U
\
c
j
q
x
'.5<CJQX_fmt{ #*18?FMT[bkry
"
)
0
7
>
E
J
O
W
d
q
v
$+29@GNU\cjqx '.5<CJQX_fmt{ #*18?FMT[bipw~
&-4;BIPW^elsz !(/6=DOVcpuz-B\v$<Tdy*5@Tanz!2>O_fmt{ $-6?HQZclu~ )2;DMV^gpy $-6?HQZclu~ )2;DM\enwcommaaccentAbreveAmacronAogonekAEacuteCacuteCcaronCcircumflexCdotaccentDcaronDcroatEbreveEcaronEdotaccentEmacronEngEogonekGbreveGcircumflexGcommaaccentGdotaccentHbarHcircumflexIbreveIJImacronIogonekItildeJcircumflexKcommaaccentLacuteLcaronLcommaaccentLdotNacuteNcaronNcommaaccentObreveOhungarumlautOmacronOslashacuteRacuteRcaronRcommaaccentSacuteScedillaScircumflexScommaaccentTbarTcaronTcommaaccentUbreveUhungarumlautUmacronUogonekUringUtildeWacuteWcircumflexWdieresisWgraveYcircumflexYgraveZacuteZdotaccentIdotaccentabreveamacronaogonekaeacutecacuteccaronccircumflexcdotaccentdcarondcroatebreveecaronedotaccentemacronengeogonekgbrevegcircumflexgcommaaccentgdotaccenthbarhcircumflexibreveijimacroniogonekitildejcircumflexkcommaaccentlacutelcaronlcommaaccentldotnacutencaronncommaaccentobreveohungarumlautomacronoslashacuteracutercaronrcommaaccentsacutescedillascircumflexscommaaccenttbartcarontcommaaccentubreveuhungarumlautumacronuogonekuringutildewacutewcircumflexwdieresiswgraveycircumflexygravezacutezdotaccentkgreenlandiclongsnapostrophetonosdieresistonosAlphaBetaGammaDeltaEpsilonZetaEtaThetaIotaKappaLambdaMuNuXiOmicronPiRhoSigmaTauUpsilonPhiChiPsiOmegaAlphatonosEpsilontonosEtatonosIotatonosIotadieresisOmicrontonosUpsilontonosUpsilondieresisOmegatonosuni1FBBuni1F09uni1F0Duni1F0Buni1F0Funi1FB8uni1FBAuni1FBCuni1F89uni1F8Duni1F8Buni1F8Funi1F88uni1F8Cuni1F8Auni1F8Euni1F08uni1F0Cuni1F0Auni1F0Euni1FB9uni1FC9uni1F19uni1F1Duni1F1Buni1FC8uni1F18uni1F1Cuni1F1Auni1FCBuni1F29uni1F2Duni1F2Buni1F2Funi1FCAuni1FCCuni1F99uni1F9Duni1F9Buni1F9Funi1F98uni1F9Cuni1F9Auni1F9Euni1F28uni1F2Cuni1F2Auni1F2Euni1FDBuni1F39uni1F3Duni1F3Buni1F3Funi1FD8uni1FDAuni1F38uni1F3Cuni1F3Auni1F3Euni1FD9uni1FFBuni1F69uni1F6Duni1F6Buni1F6Funi1FFAuni1FFCuni1FA9uni1FADuni1FABuni1FAFuni1FA8uni1FACuni1FAAuni1FAEuni1F68uni1F6Cuni1F6Auni1F6Euni1FF9uni1F49uni1F4Duni1F4Buni1FF8uni1F48uni1F4Cuni1F4Auni1FECuni1FEBuni1F59uni1F5Duni1F5Buni1F5Funi1FE8uni1FEAuni1FE9alphabetagammadeltaepsilonzetaetathetaiotakappalambdanuxiomicronpirhosigmatauupsilonphichipsiomegaalphatonosepsilontonosetatonosiotatonosiotadieresisomicrontonosupsilontonosupsilondieresisomegatonosiotadieresistonosupsilondieresistonosuni03C2uni0374uni0375uni037Euni03D0uni03DAuni03DEuni03E0uni03F0uni1FBDuni1FBEuni1FC1uni1FCDuni1FCEuni1FCFuni1FDDuni1FDEuni1FDFuni1FEDuni1FEEuni1FFEuni1F00uni1F01uni1F02uni1F03uni1F04uni1F05uni1F06uni1F07uni1F10uni1F11uni1F12uni1F13uni1F14uni1F15uni1F20uni1F21uni1F22uni1F23uni1F24uni1F25uni1F26uni1F27uni1F30uni1F31uni1F32uni1F33uni1F34uni1F35uni1F36uni1F37uni1F40uni1F41uni1F42uni1F43uni1F44uni1F45uni1F50uni1F51uni1F52uni1F53uni1F54uni1F55uni1F56uni1F57uni1F60uni1F61uni1F62uni1F63uni1F64uni1F65uni1F66uni1F67uni1F70uni1F71uni1F72uni1F73uni1F74uni1F75uni1F76uni1F77uni1F78uni1F79uni1F7Auni1F7Buni1F7Cuni1F7Duni1F80uni1F81uni1F82uni1F83uni1F84uni1F85uni1F86uni1F87uni1F90uni1F91uni1F92uni1F93uni1F94uni1F95uni1F96uni1F97uni1FA0uni1FA1uni1FA2uni1FA3uni1FA4uni1FA5uni1FA6uni1FA7uni1FB0uni1FB1uni1FB2uni1FB3uni1FB6uni1FB7uni1FC2uni1FC3uni1FC4uni1FC6uni1FC7uni1FD0uni1FD1uni1FD2uni1FD3uni1FD6uni1FD7uni1FE0uni1FE1uni1FE2uni1FE3uni1FE4uni1FE5uni1FE6uni1FF2uni1FF3uni1FF4uni1FF6uni1FF7uni1FB4uni1FE7uniEFD5anoteleiauni03D1uni03D5uni03D6franclirapesetaEuroafii61289estimatedpartialdiffproductsummationuni2219radicalinfinityintegralapproxequalnotequallessequalgreaterequallozengeuni02C9uniEFEDuniEFEEuniEFF1uniEFF2uniEFF3uniEFF5uniEFF7AcuteCaronDieresisDieresisAcuteDieresisGraveGraveHungarumlautMacroncyrBrevecyrFlexdblGravecyrbrevecyrflexdblgravedieresisacutedieresisgraveuniF635uniF637uniF638uniF639uniF6DCuniF63AuniF63BuniF63CuniF63DuniF63EuniF63FuniF640uniF641uniF642uniF628uniF643uniF644uniF645uniF646uniF647uniF648uniF649uniF64AuniF64BuniF64CuniF64DuniF64EuniF64FuniF650uniF651uniF652uniF653uniF654uniF655uniF656uniF657uniF658uniF659uniF65AuniF65BuniF65CuniF65DuniF65EuniF65FuniF660uniF629uniF62AuniF62BuniF62CuniF62DuniF661uniF662uniF663uniF664uniF665uniF666uniF667uniF668uniF669uniF66AuniF66BuniF66CuniF62EuniF62FuniF630uniF631uniF632uniF66DuniF66EuniF66FuniF670uniF671uniF672uniF673uniF674uniF675uniF676uniF677uniF678uniF679uniF67AuniF67BuniF67CuniF67DuniF67EuniF67FuniF680uniF681uniF682uniF683uniF684uniF685uniF686uniF687uniF688uniF689uniF68AuniF68BuniF68CuniF68DuniF68EuniF68FuniF690uniF691uniF692uniF693uniF694uniF695uniF696uniF697uniF698uniF699uniF69AuniF69BuniF69CuniF69DuniF69EuniF69FuniF6A0uniF6A1uniF6A2uniF6A3uniF6A4uniF6A5uniF6A6uniF6A7uniF6A8uniF6A9uniF6AAuniF6ABuniF6ACuniF6ADuniF6AEuniF6AFuniF6B0uniF6B1uniF6B2uniF6B3uniF6B4uniF6B5uniF6B6uniF6B7uniF6B8uniF6B9uniF6BAuniF6BBuniF6BCuniF6BDuniF633c_hc_kc_tf_bf_f_bf_f_hf_f_kf_f_tf_hf_jf_f_jf_kf_ts_puniFB06T_hlongs_blongs_hlongs_ilongs_klongs_llongs_longsuniFB05longs_longs_ilongs_longs_la.ende.endm.endn.endr.endK.altR.altk.altcaron.altcommaaccent.altpeseta.altAlphaiotasub.altAlphaiotasubasper.altAlphaiotasubasperacute.altAlphaiotasubaspergrave.altAlphaiotasubaspertilde.altAlphaiotasublenis.altAlphaiotasublenisacute.altAlphaiotasublenisgrave.altAlphaiotasublenistilde.altEtaiotasub.altEtaiotasubasper.altEtaiotasubasperacute.altEtaiotasubaspergrave.altEtaiotasubaspertilde.altEtaiotasublenis.altEtaiotasublenisacute.altEtaiotasublenisgrave.altEtaiotasublenistilde.altOmegaiotasub.altOmegaiotasubasper.altOmegaiotasubasperacute.altOmegaiotasubaspergrave.altOmegaiotasubaspertilde.altOmegaiotasublenis.altOmegaiotasublenisacute.altOmegaiotasublenisgrave.altOmegaiotasublenistilde.altEuro.fittedcent.fittedcolonmonetary.fitteddollar.fittedflorin.fittedfranc.fittedlira.fittednumbersign.fittedsterling.fittedyen.fittedEuro.oldstylecolonmonetary.oldstyleestimated.oldstyleflorin.oldstylefranc.oldstylelira.oldstylenumbersign.oldstylesterling.oldstyleyen.oldstylefranc.taboldstylelira.taboldstyleorn.001orn.002orn.003orn.004orn.005orn.006orn.007orn.008orn.009orn.010orn.011orn.012orn.013orn.014orn.015orn.016orn.017orn.018orn.019orn.020orn.021orn.022orn.023afii10023afii10031afii10022afii10049T_h.caronafii10070afii10196afii10026afii10021afii10846afii10193afii10107afii10024afii10195afii10041afii10037afii10109afii10053afii10045afii10108afii10040afii10104afii10036afii10078afii10074afii10060afii10046afii10052afii10087afii10050afii10145afii10057afii10059afii10146afii10088afii10101afii10054afii10058Rholenisafii10025afii10099afii10068afii10035afii10048afii10089afii10105afii10085afii10020afii10077afii10106afii10019afii10076afii10110afii10100afii10090afii10028afii10095afii10147afii10066afii10098afii10082afii10061afii10103afii10102afii10083afii10027afii10072afii10039afii61352afii10069afii10094afii10038afii10034afii10148afii10032afii10194afii10033afii10075afii10017afii10081afii10056afii10084afii10044afii10030afii10051afii10047afii10018afii10080afii10042afii10071afii10029afii10062afii10065afii10097T_h.commaaccentafii10096afii10079afii10091afii10093afii10064afii10043afii10092uni2215uni021Bafii10073afii10067uni00A0uni021Aafii10086afii10055uni0394uni03BCuni03A9uni00ADCopyright 2000 Adobe Systems Incorporated. All Rights Reserved. U.S. Patent Des. 337,604.Minion is either a registered trademark or a trademark of Adobe Systems Incorporated in the United States and/or other countries.Minion Pro RegularMinion Pro% i WZ5:`v22> % I
/
2
I
o
#3p~U
D
e
!o#]emE %<Jeov~EMfjtFp|,S-AZ0=DK +^&7NQy(/S_dl 5Rk$=Valsz"'-@T_gos{ ) . > N ^ d n v ~ !!!!'!3!?!H!Q!Z!]!c!i!n!s!x!!!!!!!!!!!!!"""#"'"3"?"K"W"c"k"s"{""""""""""""""c&oEr^7 JB@H *W2c~sp&m!1= 4:$kYyywRvzwrZnon?˘iNUddLoLݪ
~}}vywS6vO(Zp^TrǕ؍8x`?NYwUVYWE}zyMhummR~Kfowx}|txcBzuyBpOwTxql[LPҩy}~Bxxhzqlc#T0@9
5/j,X^M8Uruuoquvqiff{bE<H8XUo^bb_rMG'Н=[W}yQSSۚ$P|TzTyT'
ajqyzx||rrpwttozpj`lWHrʥaiqyo
|rqpxt@tpyqjalVHr]yt/m'mDx]pIsn8AgmxpQAz4wv~s}~vstzf|oęgfeoszvwzxu$wny|YgJO-ʆea]>9+ZhchAB_\?#^|m[5v-<<[FL LHHq˂~XxAo4uFabfqaf%f+rrs}ǔcqW "* ڟŇՊvx|po~}wUJN<0o-כtzr[ {"!coч~^o]/6'orsBp0ZlZqRoGt{_Fpq|iiMkTratap`DabuvCICpAϦ{~{lpˇBDDpӐ qoكtYoNU)gI_Z`yӔodžF/INlw71oC
ŸԱȗГnoՆ3$811xrdcQD:0] ;hJjp~djmplXhZfYxnmmyf^#MR:AgszvT]jjZ?_ynZQ{sNHyZdƨ]O틯֯}ޣDyZ{kvumofFMk_VYЄ#ms^@L A_!Z Z|蒯}~rqyg|usqrwgmazԬqbfZBoل5|%69o<3oZMZJuׇ3c T{ddmvrjY_VpŇkrkGpφ}8Fgsmy]pWSy/OBR7WXjfeolw}v84o~}xUGP~72pC
~㿊IK
NϪb98IPq
`y[~XsłI\FL
ދ.R۲vhl_@oۅ8(85oq͗ƫ>(3XOG7]_\i^%"Ba:Jy.}eu}|wzq]is|~ґϐuCDDEp
ؑ~P|xhcMp^},
qkuGuzwv~s}~ust}e{nęgfR5BcH
蠓`
i
`c
v
y
蠚}xsnyvrpyh&T~Y|S|Q4xrqxvrpyhrqVVrm